Lakefront Biotherapeutics (LKFT) Shares Outstanding (2014 - 2026)

Lakefront Biotherapeutics (LKFT) has reported Shares Outstanding (Entity) for 12 consecutive years, with $75.0 million the latest figure, recorded in Q4 2025.

• Quarterly Shares Outstanding (Entity) changed 0.0% year-over-year to $75.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $75.0 million (changed 0.0% YoY) and the FY2025 annual result came in at $75.0 million, changed 0.0% from the prior year.
• Shares Outstanding (Entity) was little changed at $75.0 million in Q4 2025 per LKFT's latest filing, from $75.0 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for LKFT reached as high as $75.0 million in Q2 2024 and fell as low as $74.5 million in Q2 2021.
• A 5-year average of $74.8 million and a median of $75.0 million in 2023 frame the typical range for Shares Outstanding (Entity).
• The largest YoY upside for Shares Outstanding (Entity) was 100553.09% in 2021 against a maximum downside of 68.44% in 2021.
• Year by year, Shares Outstanding (Entity) stood at $74.5 million in 2021, then increased by 0.3% to $74.8 million in 2022, then advanced by 0.28% to $75.0 million in 2023, then climbed by 0.02% to $75.0 million in 2024, then changed by 0.0% to $75.0 million in 2025.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $75.0 million, $75.0 million, and $75.0 million for Q4 2025, Q2 2025, and Q4 2024 respectively.